Phenytoin and Rifampin Do Not Decrease Levels in Acute Tacrolimus Toxicity
Tacrolimus is used in bone marrow transplant patients to prevent graft-versus-host disease. There have been few case reports of tacrolimus toxicity (>30 ng/mL) in solid organ recipients as well as in nontransplant patients. Several case reports suggest phenytoin and rifampin decrease tacrolimus l...
Saved in:
Main Authors: | Benjamin O. Lawson MD (Author), Heemesh Seth DO (Author), Dan Quan DO (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2018-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment of acute tacrolimus toxicity with phenytoin after Paxlovid (nirmatrelvir/ritonavir) administration in a kidney transplant recipient
by: Eun-Jeong Kwon, et al.
Published: (2022) -
Toxic epidermal necrolysis following phenytoin and cranial irradiation
by: Najeeba Riyaz, et al.
Published: (2015) -
Phenytoin Toxicity with High Dose, Concomitant Ascorbic Acid Dosing
by: Michael J. Schuh, et al.
Published: (2022) -
Case report: Supratherapeutic tacrolimus concentrations with nirmatrelvir/ritonavir in a lung transplant patient: a case report using Rifampin for reversal
by: Yu Xiong, et al.
Published: (2023) -
Various effects of repeated rifampin dosing on coproporphyrin levels in humans
by: Jonny Kinzi, et al.
Published: (2023)